These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32927364)

  • 21. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.
    Cai L; Ye Y; Jiang Q; Chen Y; Lyu X; Li J; Wang S; Liu T; Cai H; Yao K; Li JL; Li X
    Nat Commun; 2015 Jul; 6():7353. PubMed ID: 26135619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EBV miR-BART10-3p Promotes Cell Proliferation and Migration by Targeting DKK1.
    Min K; Lee SK
    Int J Biol Sci; 2019; 15(3):657-667. PubMed ID: 30745852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma.
    Hsu CY; Yi YH; Chang KP; Chang YS; Chen SJ; Chen HC
    PLoS Pathog; 2014 Feb; 10(2):e1003974. PubMed ID: 24586173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
    Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
    Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Dicer1 targeted by EBV-miR-BART6-5p on biological properties and radiosensitivity of nasopharyngeal carcinoma.
    Tang J; Liu ZY; Tang Y; Wang Y
    Hum Exp Toxicol; 2021 Jun; 40(6):977-993. PubMed ID: 33305599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma.
    Deng Y; Liu X; Huang Y; Ye J; He Q; Luo Y; Chen Y; Li Q; Lin Y; Liang R; Li Y; Wei J; Zhang J
    Cell Oncol (Dordr); 2023 Aug; 46(4):987-1000. PubMed ID: 36917356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal transfer of miR-106a-5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal carcinoma.
    Li J; Hu C; Chao H; Zhang Y; Li Y; Hou J; Huang L
    J Cell Mol Med; 2021 Oct; 25(19):9183-9198. PubMed ID: 34469038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts.
    Lee PJ; Sui YH; Liu TT; Tsang NM; Huang CH; Lin TY; Chang KP; Liu SC
    J Exp Clin Cancer Res; 2022 Aug; 41(1):254. PubMed ID: 35986369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma.
    Lei T; Yuen KS; Xu R; Tsao SW; Chen H; Li M; Kok KH; Jin DY
    Int J Cancer; 2013 Jul; 133(1):79-87. PubMed ID: 23280823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomal miR-106a-5p accelerates the progression of nasopharyngeal carcinoma through FBXW7-mediated TRIM24 degradation.
    Li CW; Zheng J; Deng GQ; Zhang YG; Du Y; Jiang HY
    Cancer Sci; 2022 May; 113(5):1652-1668. PubMed ID: 35293097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CAFs-derived exosomes promote the development of cervical cancer by regulating miR-18a-5p-TMEM170B signaling axis.
    Kang C; Duo Y; Zheng L; Zhao N; Wang J; Liu Z; Qiu L; Bi F
    Biochem Biophys Res Commun; 2024 Jan; 694():149403. PubMed ID: 38147699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
    Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
    BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
    Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW
    J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
    Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
    Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonizing exosomal miR-18a-5p derived from prostate cancer cells ameliorates metastasis-induced osteoblastic lesions by targeting Hist1h2bc and activating Wnt/β-catenin pathway.
    Zeng F; Zhao C; Wang R; Ren L; Qiu H; Zou Z; Ding H; Sun Z; Li J; Dong S
    Genes Dis; 2023 Jul; 10(4):1626-1640. PubMed ID: 37397518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
    Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
    Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
    Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
    Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma.
    Wu J; Tan X; Lin J; Yuan L; Chen J; Qiu L; Huang W
    Hum Gene Ther; 2017 May; 28(5):415-427. PubMed ID: 28042945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.